Skip to main content
NCBI home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2007 Mar;22(1):45–51. doi: 10.1007/BF02912880

Antioxidant status in patients with acute myocardial infarction

Neela Patil 1,✉, Vishwas Chavan 1, N D Karnik 2
PMCID: PMC3454265  PMID: 23105651

Abstract

Free radicals play an important role in the pathogenesis of tissue damage in many clinical disorders, including atherosclerosis. Antioxidants protect the body from damage caused by free radicals. In this study we investigated oxidative stress, antioxidants and inflammatory molecules in patients with acute myocardial infarction. This study has been carried out on 106 patients with acute myocardial infarction, (89 men and 17 females). The control group consisted of 50 healthy, age-matched subjects (40 men and 10 females). Levels of Glucose, lipid profile, glutathione reduced, glutathione peroxidase, Superoxide dismutase, Glycosylated hemoglobin, fibrinogen, vitamin C, vitamin E, malondialdehyde, ceruloplasmin, adenosine deaminase, lysozyme and sialic acid were measured. Malondialdehyde and ceruloplasmin levels were significantly high and antioxidants such as vitamin C, vitamin E, glutathione reduced, glutathione peroxidase and superoxide dismutase were significantly decreased in diabetic and non-diabetic AMI patients as compared with control (p<0.001). Inflammatory markers showed significant rise in diabetic patients as compared with controls. Our results clearly show increased inflammation and oxidative stress in patients with acute myocardial infarction. Depression of antioxidant system in these patients confirms this conclusion.

Key words: Oxidative Stress, Antioxidant, Inflammation and AMI

Full Text

The Full Text of this article is available as a PDF (80.0 KB).

References

  • 1.Carrol CE. Oxygen free radicals and human disease. Ann Int Med. 1987;107:526–45. doi: 10.7326/0003-4819-107-4-526. [DOI] [PubMed] [Google Scholar]
  • 2.Shrinivas K, Vijaya Bhaskar M, Aruna Kumari R, Nagaraj K, Reddy KK. Antioxidants, lipid peroxidation and lipoproteins in primary hypertension. Indian Heart J. 2000;52:285–8. [PubMed] [Google Scholar]
  • 3.Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Cann B, et al. Factors associated with oxidative stress in human populations. Am J Epidemiol. 2002;156:274–85. doi: 10.1093/aje/kwf029. [DOI] [PubMed] [Google Scholar]
  • 4.Libby P. Vascular biology of atherosclerosis: Overview and state of art. Am J Cardiol. 2003;91:3A–6A. doi: 10.1016/S0002-9149(02)03143-0. [DOI] [PubMed] [Google Scholar]
  • 5.Beutler E, Duran O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med. 1963;61(5):882–8. [PubMed] [Google Scholar]
  • 6.Paglia DE, Valentine WN. Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158–69. [PubMed] [Google Scholar]
  • 7.Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J Lab Clin Med. 1975;85(2):337–41. [PubMed] [Google Scholar]
  • 8.Fluckiger R, Winterhalter KH. In vitro synthesis of hemoglobin A1G. FEBS Lett. 1976;71:356–60. doi: 10.1016/0014-5793(76)80969-6. [DOI] [PubMed] [Google Scholar]
  • 9.Varley H, Gowenlock AH, Bell M. Practical Clinical Biochemistry. 5th edition. London: Heinemann Medical Books; 1986. Determination of plasma fibrinogen by tyrosine method (Lampert) [Google Scholar]
  • 10.Varley H. Determination of plasma ascorbate by 2,6-Dichlorophenolindophenol titration. In: Gowenlock AH, McMurray JR, McLauchlan DM, editors. Varley's Practical Clinical Biochemistry. 6TH edition. London: Heinemann Medical Books; 1988. pp. 927–927. [Google Scholar]
  • 11.Baker H, Frank O. Determination of serum tocopherol. In: Gowenlock AH, McMurray JR, McLauchlan DM, editors. Varley's Practical Clinical Biochemistry. 6TH edition. London: Heinemann Medical Books; 1988. pp. 902–902. [Google Scholar]
  • 12.Sasikala M, Subramanyam C, Sadasivudu B. Early oxidative change in low density lipoproteins during progressive chronic renal failure. Ind J Clin Biochem. 1999;14(2):176–83. doi: 10.1007/BF02867916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ravin HA. An improved colorimetric enzymatic assay of ceruloplasmin. J Lab Clin Med. 1961;58(1):161–8. [PubMed] [Google Scholar]
  • 14.Martinek RG. Micromethod for estimation of serum adenosine deaminase. Clin Chem. 1963;9(5):620–25. [PubMed] [Google Scholar]
  • 15.Harrison JF, Lunt GS, Scott P, Blainey JD. Urinary lysozyme, ribonuclease and low molecular weight protein in renal disease. Lancet. 1968;1:371–5. doi: 10.1016/S0140-6736(68)91350-0. [DOI] [PubMed] [Google Scholar]
  • 16.Cabezas JA, Vazquez Porto J. Sialic acid in human serum. Clin Chem. 1964;10(11):986–90. [PubMed] [Google Scholar]
  • 17.Dubois-Rande JL, Artigou JY, Darmon JY, Habbal R, Manuel C, Tayarani I, et al. Oxidative stress in patients with unstable angina. Eur Heart J. 1994;15(2):179–83. doi: 10.1093/oxfordjournals.eurheartj.a060473. [DOI] [PubMed] [Google Scholar]
  • 18.McMurray J. Evidence of oxidative stress in chronic heart failure in humans. Eur Heart J. 1993;14(11):1493–7. doi: 10.1093/eurheartj/14.11.1493. [DOI] [PubMed] [Google Scholar]
  • 19.Engstrom G, Stavenow L, Hedblad B, Lind P, Eriksson KF, Janzon L, et al. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study. Diabetes. 2003;52(2):442–47. doi: 10.2337/diabetes.52.2.442. [DOI] [PubMed] [Google Scholar]
  • 20.Fox PL, Mukhopadhyay C, Ehrenwald E. Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin. Life-Sci. 1995;56(21):1749–58. doi: 10.1016/0024-3205(95)00146-W. [DOI] [PubMed] [Google Scholar]
  • 21.Singh RB, Niaz MA, Sharma JP, Kumar R, Bishnoi I, Begom R. Plasma levels of antioxidant vitamins and oxidative stress in patients with acute myocardial infarction. Acta Cardiol. 1994;49:441–52. [PubMed] [Google Scholar]
  • 22.Kharb S. Low blood glutathione levels in acute myocardial infarction. Ind J Med Sci. 2003;57(8):335–7. [PubMed] [Google Scholar]
  • 23.Kumar KV, Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun. 1993;19(1):59–66. doi: 10.3109/10715769309056499. [DOI] [PubMed] [Google Scholar]
  • 24.Stec JJ, Silbershatz H, Tofler GH, Matheney TH, Sutherland P, Lipinska I, et al. Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham offspring population. Circulation. 2000;102(14):1634–38. doi: 10.1161/01.cir.102.14.1634. [DOI] [PubMed] [Google Scholar]
  • 25.Hackam DG, Anand SS. Emerging risk factors for atherosclerotic vascular disease. JAMA-India. 2004;3(2):34–41. doi: 10.1001/jama.290.7.932. [DOI] [PubMed] [Google Scholar]
  • 26.Jose J, Selvakumar D, Selvakumar R, Kanagasapabathy AS, Jeyaseelan L. Plasma fibrinogen-an independent risk factor for ischemic heart disease. Ind Heart J. 1998;50(1):45–8. [PubMed] [Google Scholar]
  • 27.Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease. JAMA. 1987;258(9):1183–6. doi: 10.1001/jama.258.9.1183. [DOI] [PubMed] [Google Scholar]
  • 28.Acevedo M, Foody JM, Pearce GL, Sprecher DL. Fibrinogen: Association with cardiovascular events in an outpatient clinic. Am Heart J. 2002;143(2):277–82. doi: 10.1067/mhj.2002.119766. [DOI] [PubMed] [Google Scholar]
  • 29.Sari RA, Taysi S, Yilmaz O, Bakan N. Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin Exp Rheumatol. 2003;21(1):87–90. [PubMed] [Google Scholar]
  • 30.Frode TS, Medeiros YS. Myeloperoxidase and adenosine deaminase levels in the pleural fluid leakage induced by carrageenan in the mouse model of pleurisy. Mediators Inflamm. 2001;10(4):223–7. doi: 10.1080/09629350120080429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kurtul N, Pence S, Akarsu E, Kocoglu H, Aksoy Y, Aksoy H. Adenosine deaminase activity in the serum of type 2 diabetic patients. Acta Medica (Hradec Kralove) 2004;47(1):33–5. [PubMed] [Google Scholar]
  • 32.Welman E, Colbeck JF, Selwyn AP, Fox KM, Orr I. Plasma lysosomal enzyme activity in acute myocardial infarction and the effects of drugs. Adv Myocardiol. 1980;2:359–69. [PubMed] [Google Scholar]
  • 33.Welman E, Selwyn AP, Peters TJ, Colbeck JF, Fox KM. Plasma lysosomal enzyme activity in acute myocardial infarction. Cardiovasc Res. 1978;12(2):99–105. doi: 10.1093/cvr/12.2.99. [DOI] [PubMed] [Google Scholar]
  • 34.Hickey NC, Gosling P, Barr S, Shearman CP, Simms MH. Effect of surgery on the systemic inflammatory response to intermittent claudication. Br J Surg. 1990;77(10):1121–4. doi: 10.1002/bjs.1800771015. [DOI] [PubMed] [Google Scholar]
  • 35.Crook MA, Goldsmith L, Ameerally P, Lumb P, Singh N, Miell J, et al. Serum sialic acid, a possible cardiovascular risk factor is not increased in Fijian Melanesians with impaired glucose tolerance or impaired fasting glucose. Ann Clin Biochem. 2002;39(6):606–8. doi: 10.1258/000456302760413414. [DOI] [PubMed] [Google Scholar]
  • 36.Haffner SM. Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors. Circulation. 2001;103(3):346–7. doi: 10.1161/01.cir.103.3.346. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES